Goodwin’s Elaine Blais, Scott Lassman and Alex Valenti to host a Biosimilars Market Update Webinar

On November 6th, Goodwin’s Elaine Blais, Scott Lassman and Alex Valenti will be hosting a Biosimilars Market Update webinar, discussing key issues and recent legal and regulatory developments in the biosimilars space. Topics will include recent antitrust claims filed against biologic manufacturers, new strategies in BPCIA litigation, updates on legal developments affecting validity challenges at the U.S. Patent & Trademark Office, a discussion of transitional biologics and exclusivity and REMS issues that may be affecting biosimilar availability in the U.S. To register please click here.

 

Download PDF